<DOC>
	<DOCNO>NCT01463345</DOCNO>
	<brief_summary>The objective study examine safety two different hemoglobin ( Hgb ) -based transfusion trigger patient post cardiac surgery .</brief_summary>
	<brief_title>Blood Conservation Cardiac Surgery</brief_title>
	<detailed_description>Nearly 20 % blood transfusion United States give patient undergo cardiac surgery . Despite many blood conservation technique available , safe , efficacious patient , many operation continue associate significant amount blood usage . We believe transfusion protocol employ specific guideline transfusion decrease blood product usage improve outcome patient undergo cardiac surgery . Our goal demonstrate carefully choose trigger achieve good outcome . Our hypothesis transfusion trigger Hgb 7.5 g/dl lead decrease utilization blood transfusion many positive effect patient post cardiac surgery addition substantial cost saving . We use evidence base approach observe relative safety conservative transfusion trigger ( 7.5 g/dl ) compare liberal trigger ( 9.0 g/dl ) . We also study effect blood conservation incidence transfusion-related complication transfusion relate lung injury ( TRALI ) infectious complication well length hospital stay , cost ventilator time .</detailed_description>
	<mesh_term>Transfusion Reaction</mesh_term>
	<criteria>Subjects meet follow criterion consider inclusion study : 1 . Subjects schedule undergo follow cardiac surgery part routine medical care : CABG AVR MVR MV Repair CABG/AVR CABG/MVR CABG/MV Repair Thoracic Aneurysm Repair ± concomitant cardiac procedure ( valve , CABG , etc . ) 2 . Subjects must &gt; 18 year age 3 . No prior history cardiac surgery . 4 . Able willing give inform consent Subjects meet follow criterion exclude participation study : 1 . Prior history cardiac surgery 2 . Patients sufficient time prior surgery give proper inform consent ( i.e . : immediate , emergency surgery ) 3 . Patients young 18 year age 4 . Prior history bleed disorder symptomatic anemia ( i.e . persistent tachycardia , orthostatic hypotension , persistent pressor requirement ) hereditary/acquired coagulopathy platelet defect ( e.g . : disseminated intravascular coagulation ( DIC ) , hemophilia , HenochSchönlein purpura , hereditary hemorrhagic telangiectasia , thrombocytopenia ( ITP , TTP ) , thrombophilia , Von Willebrand 's disease ) 5 . History leukemia blood related malignancy 6 . History liver failure 7 . Current , history , preexist medical condition current cardiac condition , opinion investigator , would place subject risk potential confound interpretation study result 8 . Participation another clinical trial 9 . Lack capacity give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Blood conservation</keyword>
	<keyword>Transfusion</keyword>
	<keyword>Hemoglobin trigger</keyword>
	<keyword>Transfusion trigger</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Transfusion trigger post cardiac surgery</keyword>
</DOC>